Cardiac Surgery-Associated Acute Kidney Injury: Current Update and Perspectives
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: 14 September 2024 | Viewed by 33912
Special Issue Editors
2. BioCritic. Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain
Interests: personalised medicine; cardiac surgery associated acute kidney injury; cardiac surgery perioperatory management and anesthesia; sepsis; perioperative cognitive decline; delirium
Interests: cardiac surgery associated acute kidney injury; endocarditis; perioperative care
2. BioCritic. Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain
Interests: acute kidney injury; cardiac surgery associated acute kidney injury; cardiac surgery perioperatory management and anesthesia; sepsis
Special Issue Information
Dear Colleagues,
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a recognized and serious complication and one of the stronger risk factors for mortality in patients undergoing cardiac surgery. In its more severe form, it increases the likelihood of death by 50%-80%. Even a mild increase in serum creatinine after cardiac surgery entails a higher morbidity with longer length of stay in both hospital and intensive care unit and higher costs of care.
Despite all the recent advancements, we need to improve both our general understanding and our capacity to effectively diagnose, treat and/or prevent CSA-AKI, as it still is a widely held concern and remains as a threat to the critical care team. This Special Issue aims not only to provide an updated comprehensive approach of this disease, in which milieu of factors are intertwined, but also to introduce the latest advances in diagnosis, treatment, and prevention strategies to try to properly tackle this issue.
On behalf of the Journal of Clinical Medicine, we are kindly inviting authors to contribute to the Special Issue “Cardiac Surgery-Associated Acute Kidney Injury: Current Update and Perspectives”. Original articles and Reviews are welcome.
Dr. Eduardo Tamayo
Dr. Christian Ortega-Loubon
Dr. Pablo Jorge-Monjas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute kidney injury
- cardiac surgery associated acute kidney injury
- CSA-AKI risk factors and prediction scores
- perioperative Management, Goal directed perioperative care for CSA-AKI prevention
- goal directed perfusion strategy
- diagnosis
- monitoring renal function
- biomarkers
- prevention
- fluids and diuretics for CSA-AKI
- renal replacement therapy for CSA-AKI
- renal replacement therapy for immunomodulation in high risk cardiac surgery